Abstract: The present invention provides substituted tricyclic compound of formula (I), which are therapeutically useful as KRAS degraders. These compounds are useful in the treatment and/or prevention of diseases or disorders dependent upon KRAS. The present invention also provides pharmaceutical compositions comprising a compound of formula (I) or a pharmaceutically acceptable salt or a stereoisomer or a tautomer thereof thereof.
| # | Name | Date |
|---|---|---|
| 1 | 202647058525-NOTIFICATION OF INT. APPLN. NO. & FILING DATE (PCT-RO-105-PCT Pamphlet) [07-05-2026(online)].pdf | 2026-05-07 |
| 2 | 202647058525-FORM 1 [07-05-2026(online)].pdf | 2026-05-07 |
| 3 | 202647058525-DRAWINGS [07-05-2026(online)].pdf | 2026-05-07 |
| 4 | 202647058525-COMPLETE SPECIFICATION [07-05-2026(online)].pdf | 2026-05-07 |
| 5 | 202647058525-CLAIMS UNDER RULE 1 (PROVISIO) OF RULE 20 [07-05-2026(online)].pdf | 2026-05-07 |
| 6 | 202647058525-FORM-5 [08-05-2026(online)].pdf | 2026-05-08 |
| 7 | 202647058525-FORM 3 [08-05-2026(online)].pdf | 2026-05-08 |
| 8 | 202647058525-FORM 18 [08-05-2026(online)].pdf | 2026-05-08 |
| 9 | 202647058525-WIPO_PCT_DOC.pdf | 2026-05-17 |
| 10 | 202647058525-PATENT_APPLICATION_PUBLICATION.pdf | 2026-05-30 |